Markets:

Overview

News

Currencies

International

Treasuries

iShares U.S. Healthcare ETF (NY:IYH)

75.92 +0.44 (+0.58%)

Delayed Quote Updated: 2:09 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares U.S. Healthcare ETF

< Previous 1 2 3 4 Next >

Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' ↗

November 18, 2025

Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.

Via Benzinga

Topics ETFs

FDA To Ease Review Process For Life-Saving Gene-Editing Therapies: Report ↗

October 31, 2025

Via Stocktwits

Why Is Co-Diagnostics Stock Sinking Tuesday? ↗

October 28, 2025

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.

Via Benzinga

Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗

October 22, 2025

DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.

Via Benzinga

Topics Artificial Intelligence

Trump Says He's 'Happy To Work' With Democrats On 'Failed' Healthcare Policies, But Calls To End Government Shutdown ↗

October 06, 2025

Via Stocktwits

Topics Government

Retail Traders Evenly Split About Government Shutdown Odds: Strategists Weigh In On Whether Jobs Report Would Be Delayed Amid Looming Risk ↗

September 29, 2025

Via Stocktwits

Premier Set For Private Ownership, Eyes Growth Push ↗

September 22, 2025

Premier Inc. to be acquired by Patient Square Capital at $28.25 per share, offering shareholders a 23.8% premium.

Via Benzinga

As the Market Rotates, This Healthcare ETF Is Leading the Way ↗

August 26, 2025

Health care saw some of the worst losses this year. But as the calendar turned to August, it's been leading the market higher. This ETF provides exposure.

Via MarketBeat

Topics ETFs

Brace For Higher Healthcare Premiums In 2026 As Insurers Blame Trump's Tariffs In Filings To Regulators: Report ↗

June 19, 2025

Health insurance companies have raised concerns that tariffs could lead to higher premiums for enrollees in the individual and small group markets next year.

Via Benzinga

Topics Government World Trade

Omada Health Prices $150M IPO In-Line With Estimated Range ↗

June 06, 2025

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18.00 and $20.00 per share

Via Stocktwits

Topics Initial Public Offering

Guardian Pharmacy Strengthens US Footprint With New Seattle-Area Acquisition ↗

June 02, 2025

Guardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest and meeting growing demand for LTC support.

Via Benzinga

Tariffs Bite Dan Loeb's Portfolio: Thermo Fisher Hit Hard, Discover Shines ↗

April 28, 2025

Year to date, Thermo Fisher fell about 21.03%, both underperforming the iShares U.S. Healthcare ETF, which declined about 2.36%.

Via Benzinga

Topics ETFs

Healthcare Sector Trying To Bounce Back ↗

March 09, 2025

I often discuss highly rated stocks that are part of highly rated sectors. Thus, this time is a departure from the norm. Let's dive into the data for the healthcare sector.

Via Talk Markets

Topics ETFs Stocks / Equities

Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars? ↗

March 04, 2025

Healthcare performed terribly in 2023 and 2024, falling while the market was soaring. Year-to-date, the sector has outperformed. Is it time to focus on the stocks and ETFs of this low-Beta sector as...

Via Talk Markets

Topics ETFs Stocks / Equities

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst ↗

February 24, 2025

Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.

Via Benzinga

Spotify, Vertiv Holdings And More: CNBC's 'Final Trades' ↗

February 13, 2025

Joseph M. Terranova picked Spotify Technology, which reported better-than-expected fiscal fourth-quarter 2024 financial sales.

Via Benzinga

US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget ↗

February 11, 2025

A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.

Via Benzinga

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements ↗

January 22, 2025

Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.

Via Benzinga

Topics Government

ETFs In Focus Post UnitedHealth's Mixed Q4 Results ↗

January 18, 2025

UnitedHealth Group, the largest U.S. health insurer, reported mixed fourth-quarter 2024 results. Shares of the stock dropped nearly 6% on the day following the results. This put various ETFs in the...

Via Talk Markets

Topics ETFs Stocks / Equities

Intuitive Surgical Stock Hits All-Time High After Prelim Q4 Results Outpace Expectations: Retail Goes All In ↗

January 15, 2025

Intuitive said worldwide da Vinci procedure volumes grew 18% in Q4 and 17% in 2024, driven by U.S. general surgery and international cancer procedures.

Via Stocktwits

Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252% ↗

December 20, 2024

Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million.

Via Benzinga

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services ↗

December 19, 2024

U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.

Via Benzinga

Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares ↗

December 13, 2024

Recently, the company announced a massive $15 billion share buyback plan and a 15% dividend increase.

Via Benzinga

Topics ETFs

FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' ↗

November 13, 2024

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.

Via Benzinga

Topics Government

What Lies In Store For Healthcare ETFs In Q3 Earnings? ↗

October 27, 2024

The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited.

Via Talk Markets

Topics ETFs

Deere, Amgen, Copart And More: CNBC's 'Final Trades' ↗

October 10, 2024

On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Deere & Company as his final trade.

Via Benzinga

Defensive ETFs Shine Amid A Rough Start To September ↗

September 04, 2024

U.S. stocks started September on a dismal note on economic slowdown concerns following weak data, which shows that manufacturing shrank again in August.

Via Talk Markets

Topics ETFs

AbbVie, Leidos, KKR And More On CNBC's 'Final Trades' ↗

August 06, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.